These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2899938)

  • 1. Sequential presentation of a case of hyperthyroidism with autonomously functioning nodules and Graves' disease in the presence of IgG thyroid stimulators.
    Smyth PP; Neylan D; McMullan NM; Smith DF; McKenna TJ
    Acta Endocrinol (Copenh); 1988 Aug; 118(4):474-8. PubMed ID: 2899938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid growth-stimulating immunoglobulins in goitrous disease: relationship to thyroid-stimulating immunoglobulins.
    Smyth PP; McMullan NM; Grubeck-Loebenstein B; O'Donovan DK
    Acta Endocrinol (Copenh); 1986 Mar; 111(3):321-30. PubMed ID: 2870597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism.
    Kraiem Z; Glaser B; Yigla M; Pauker J; Sadeh O; Sheinfeld M
    J Clin Endocrinol Metab; 1987 Oct; 65(4):659-64. PubMed ID: 2888784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro generation of NADPH as an index of thyroid stimulating immunoglobulins (TGI) in goitrous disease.
    McMullan NM; Smyth PP
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):269-80. PubMed ID: 6144407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T3-release from autonomously functioning thyroid nodules in vitro.
    Poertl S; Kirner J; Saller B; Mann K; Hoermann R
    Exp Clin Endocrinol Diabetes; 1998; 106(6):489-93. PubMed ID: 10079030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre.
    Chiovato L; Santini F; Vitti P; Bendinelli G; Pinchera A
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):803-6. PubMed ID: 8033373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?
    Brown RS; Jackson IM; Pohl SL; Reichlin S
    Lancet; 1978 Apr; 1(8070):904-6. PubMed ID: 76846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of thyroid-stimulating antibodies in goitrous disease assessed by cytochemical section bioassay.
    Smyth PP; Neylan D; O'Donovan DK
    J Clin Endocrinol Metab; 1982 Feb; 54(2):357-61. PubMed ID: 6119323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of thyroid scanning in hyperthyroidism.
    Fogelman I; Cooke SG; Maisey MN
    Eur J Nucl Med; 1986; 11(10):397-400. PubMed ID: 3009197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Can growth-stimulating immunoglobulins (TGI) explain sporadic euthyroid goiters?].
    Doniach D
    Ann Endocrinol (Paris); 1982 Dec; 43(6):534-47. PubMed ID: 6134494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implications of "thyroid-growth-immunoglobulins" (TGI) for the understanding of sporadic nontoxic nodular goitre.
    Doniach D; Chiovato L; Hanafusa T; Bottazzo GF
    Springer Semin Immunopathol; 1982; 5(4):433-46. PubMed ID: 6131546
    [No Abstract]   [Full Text] [Related]  

  • 13. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hemiagenesis with Graves' disease, Graves' ophthalmopathy and multinodular goiter.
    Cakir M; Gonen S; Dikbas O; Ozturk B
    Intern Med; 2009; 48(12):1047-9. PubMed ID: 19525596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid epithelial cell proliferation in xenotransplanted human toxic nodular goitre is increased by Graves' IgG.
    Smeds S; Jörtsö E; Tegler L
    Acta Endocrinol (Copenh); 1991 Oct; 125(4):416-9. PubMed ID: 1957560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stable, reproducible radioreceptorassay for thyrotropin binding inhibiting immunoglobulins (TBII).
    Bliddal H
    Scand J Clin Lab Invest; 1981 Sep; 41(5):441-9. PubMed ID: 6118939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathyroidal lymphocytes from non toxic multinodular goiter: no evidence for production of thyroid stimulating antibodies.
    Mavilia C; Vallin E; Frediani U; Rotella CM; Toccafondi R
    Autoimmunity; 1990; 6(4):239-48. PubMed ID: 1983328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthyroidism and thyroid cancer.
    Edmonds CJ; Tellez M
    Clin Endocrinol (Oxf); 1988 Feb; 28(2):253-9. PubMed ID: 3168308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard dose 131I therapy for hyperthyroidism caused by autonomously functioning thyroid nodules.
    Ng Tang Fui SC; Maisey MN
    Clin Endocrinol (Oxf); 1979 Jan; 10(1):69-77. PubMed ID: 436306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
    McKenzie JM; Zakarija M
    J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.